Customizable DNA labels can selectively guide drug carriers to cancer cells

Cells naturally send tiny packages to one another to share information. Researchers at Carnegie Mellon University have developed a simple, low-cost way to turn those packages into drug carriers that can deliver treatments directly to cancer cells, potentially improving effectiveness while reducing side effects.